Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review

Table of Contents

PreviousNext

September 01 2018; volume 41 issue 9

In This Issue

  • Open Access
    In This Issue of Diabetes Care
    Diabetes Care 2018 Sep; 41 (9): 1833-1834. https://doi.org/10.2337/dc18-ti09
    Add to Selected Citations

Perspectives in Care

  • You have accessRestricted Access
    Considerations in Epidemiologic Definitions of Undiagnosed Diabetes
    Linda S. Geiss, Kai McKeever Bullard, Ralph Brinks and Edward W. Gregg
    Diabetes Care 2018 Sep; 41 (9): 1835-1838. https://doi.org/10.2337/dc17-1838
    Add to Selected Citations

Commentaries

  • Open Access
    Increasing Hospitalizations for DKA: A Need for Prevention Programs
    Priyathama Vellanki and Guillermo E. Umpierrez
    Diabetes Care 2018 Sep; 41 (9): 1839-1841. https://doi.org/10.2337/dci18-0004
    Add to Selected Citations
  • Open Access
    Is Mini-Dose Glucagon the Answer to Preventing Exercise-Related Dysglycemia?
    Jessica R. Castle
    Diabetes Care 2018 Sep; 41 (9): 1842-1843. https://doi.org/10.2337/dci18-0024
    Add to Selected Citations

Clinical Care/Education/Nutrition/Psychosocial Research

  • You have accessRestricted Access
    Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data
    John M. Dennis, William E. Henley, Michael N. Weedon, Mike Lonergan, Lauren R. Rodgers, Angus G. Jones, William T. Hamilton, Naveed Sattar, Salim Janmohamed, Rury R. Holman, Ewan R. Pearson, Beverley M. Shields and Andrew T. Hattersley, on behalf of the MASTERMIND Consortium
    Diabetes Care 2018 Sep; 41 (9): 1844-1853. https://doi.org/10.2337/dc18-0344
    Add to Selected Citations
  • You have accessRestricted Access
    High Diabetes Distress Among Ethnic Minorities Is Not Explained by Metabolic, Cardiovascular, or Lifestyle Factors: Findings From the Dutch Diabetes Pearl Cohort
    Behiye Özcan, Femke Rutters, Frank J. Snoek, Mandy Roosendaal, Eric J. Sijbrands, Petra J.M. Elders, Frits Holleman, Hanno Pijl, Cees J. Tack, Evertine J. Abbink, Harold W. de Valk, Bruce H.R. Wolffenbuttel, Coen D.A. Stehouwer, Nicholas C. Schaper, Jacqueline M. Dekker and Miranda T. Schram, on behalf of the Diabetes Pearl from the Parelsnoer Initiative
    Diabetes Care 2018 Sep; 41 (9): 1854-1861. https://doi.org/10.2337/dc17-2181
    Add to Selected Citations
  • You have accessRestricted Access
    T1-REDEEM: A Randomized Controlled Trial to Reduce Diabetes Distress Among Adults With Type 1 Diabetes
    Lawrence Fisher, Danielle Hessler, William H. Polonsky, Umesh Masharani, Susan Guzman, Vicky Bowyer, Lisa Strycker, Andrew Ahmann, Marina Basina, Ian Blumer, Charles Chloe, Sarah Kim, Anne L. Peters, Martha Shumway, Karen Weihs and Patricia Wu
    Diabetes Care 2018 Sep; 41 (9): 1862-1869. https://doi.org/10.2337/dc18-0391
    Add to Selected Citations

Epidemiology/Health Services Research

  • You have accessRestricted Access
    Trends in Hospital Admission for Diabetic Ketoacidosis in Adults With Type 1 and Type 2 Diabetes in England, 1998–2013: A Retrospective Cohort Study
    Victor W. Zhong, Juhaeri Juhaeri and Elizabeth J. Mayer-Davis
    Diabetes Care 2018 Sep; 41 (9): 1870-1877. https://doi.org/10.2337/dc17-1583
    Add to Selected Citations
  • You have accessRestricted Access
    Adiposity-Mortality Relationships in Type 2 Diabetes, Coronary Heart Disease, and Cancer Subgroups in the UK Biobank, and Their Modification by Smoking
    David A. Jenkins, Jack Bowden, Heather A. Robinson, Naveed Sattar, Ruth J.F. Loos, Martin K. Rutter and Matthew Sperrin
    Diabetes Care 2018 Sep; 41 (9): 1878-1886. https://doi.org/10.2337/dc17-2508
    Add to Selected Citations
  • Open Access
    A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk
    Maria J. Redondo, Susan Geyer, Andrea K. Steck, Seth Sharp, John M. Wentworth, Michael N. Weedon, Peter Antinozzi, Jay Sosenko, Mark Atkinson, Alberto Pugliese, Richard A. Oram and the Type 1 Diabetes TrialNet Study Group
    Diabetes Care 2018 Sep; 41 (9): 1887-1894. https://doi.org/10.2337/dc18-0087
    Add to Selected Citations
  • You have accessRestricted Access
    Effects of High Blood Pressure on Cardiovascular Disease Events Among Chinese Adults With Different Glucose Metabolism
    Jingyan Tian, Chang-Sheng Sheng, Weihong Sun, Xiaomin Song, Haiyan Wang, Qifang Li, Wenyi Li and Weiqing Wang
    Diabetes Care 2018 Sep; 41 (9): 1895-1900. https://doi.org/10.2337/dc18-0918
    Add to Selected Citations
  • You have accessRestricted Access
    Biochemical Markers of Bone Turnover and Risk of Incident Diabetes in Older Women: The Cardiovascular Health Study
    Daniele Massera, Mary L. Biggs, Marcella D. Walker, Kenneth J. Mukamal, Joachim H. Ix, Luc Djousse, Rodrigo J. Valderrábano, David S. Siscovick, Russell P. Tracy, Xiaonan Xue and Jorge R. Kizer
    Diabetes Care 2018 Sep; 41 (9): 1901-1908. https://doi.org/10.2337/dc18-0849
    Add to Selected Citations

Emerging Therapies: Drugs and Regimens

  • You have accessRestricted Access
    Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes
    Michael R. Rickels, Stephanie N. DuBose, Elena Toschi, Roy W. Beck, Alandra S. Verdejo, Howard Wolpert, Martin J. Cummins, Brett Newswanger and Michael C. Riddell, for the T1D Exchange Mini-Dose Glucagon Exercise Study Group
    Diabetes Care 2018 Sep; 41 (9): 1909-1916. https://doi.org/10.2337/dc18-0051
    Add to Selected Citations
  • You have accessRestricted Access
    Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes
    Michael J. Haller, Desmond A. Schatz, Jay S. Skyler, Jeffrey P. Krischer, Brian N. Bundy, Jessica L. Miller, Mark A. Atkinson, Dorothy J. Becker, David Baidal, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Kevan C. Herold, Jennifer B. Marks, Antoinette Moran, Henry Rodriguez, William Russell, Darrell M. Wilson, Carla J. Greenbaum and the Type 1 Diabetes TrialNet ATG-GCSF Study Group
    Diabetes Care 2018 Sep; 41 (9): 1917-1925. https://doi.org/10.2337/dc18-0494
    Add to Selected Citations
  • You have accessRestricted Access
    A 26-Week Randomized Controlled Trial of Semaglutide Once Daily Versus Liraglutide and Placebo in Patients With Type 2 Diabetes Suboptimally Controlled on Diet and Exercise With or Without Metformin
    Ildiko Lingvay, Cyrus V. Desouza, Katarina S. Lalic, Ludger Rose, Thomas Hansen, Jeppe Zacho and Thomas R. Pieber
    Diabetes Care 2018 Sep; 41 (9): 1926-1937. https://doi.org/10.2337/dc17-2381
    Add to Selected Citations
  • You have accessRestricted Access
    Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
    Chantal Mathieu, Paresh Dandona, Pieter Gillard, Peter Senior, Christoph Hasslacher, Eiichi Araki, Marcus Lind, Stephen C. Bain, Serge Jabbour, Niki Arya, Lars Hansen, Fredrik Thorén and Anna Maria Langkilde, on behalf of the DEPICT-2 Investigators
    Diabetes Care 2018 Sep; 41 (9): 1938-1946. https://doi.org/10.2337/dc18-0623
    Add to Selected Citations

Pathophysiology/Complications

  • You have accessRestricted Access
    Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 Diabetes
    Andreas Heinzel, Michael Kammer, Gert Mayer, Roman Reindl-Schwaighofer, Karin Hu, Paul Perco, Susanne Eder, Laszlo Rosivall, Patrick B. Mark, Wenjun Ju, Matthias Kretzler, Peter Gilmour, Jonathan M. Wilson, Kevin L. Duffin, Moustafa Abdalla, Mark I. McCarthy, Georg Heinze, Hiddo L. Heerspink, Andrzej Wiecek, Maria F. Gomez and Rainer Oberbauer, for the BEAt-DKD Consortium
    Diabetes Care 2018 Sep; 41 (9): 1947-1954. https://doi.org/10.2337/dc18-0532
    Add to Selected Citations
  • You have accessRestricted Access
    Risk-Factor Trajectories Preceding Diabetic Polyneuropathy: ADDITION-Denmark
    Signe T. Andersen, Daniel R. Witte, Henning Andersen, Lasse Bjerg, Niels Henrik Bruun, Marit E. Jørgensen, Nanna B. Finnerup, Torsten Lauritzen, Troels S. Jensen, Hatice Tankisi and Morten Charles
    Diabetes Care 2018 Sep; 41 (9): 1955-1962. https://doi.org/10.2337/dc18-0392
    Add to Selected Citations
  • Open Access
    Renal and Cardiovascular Risk According to Tertiles of Urinary Albumin-to-Creatinine Ratio: The Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)
    M. Loredana Marcovecchio, Scott T. Chiesa, Jane Armitage, Denis Daneman, Kim C. Donaghue, Timothy W. Jones, Farid H. Mahmud, Sally M. Marshall, H. Andrew W. Neil, R. Neil Dalton, John Deanfield and David B. Dunger, on behalf of the Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT) Study Group
    Diabetes Care 2018 Sep; 41 (9): 1963-1969. https://doi.org/10.2337/dc18-1125
    Add to Selected Citations

Cardiovascular and Metabolic Risk

  • You have accessRestricted Access
    Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study
    John B. Buse, Satish K. Garg, Julio Rosenstock, Timothy S. Bailey, Phillip Banks, Bruce W. Bode, Thomas Danne, Jake A. Kushner, Wendy S. Lane, Pablo Lapuerta, Darren K. McGuire, Anne L. Peters, John Reed, Sangeeta Sawhney and Paul Strumph
    Diabetes Care 2018 Sep; 41 (9): 1970-1980. https://doi.org/10.2337/dc18-0343
    Add to Selected Citations
  • You have accessRestricted Access
    HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
    Thomas Danne, Bertrand Cariou, Phillip Banks, Michael Brandle, Helmut Brath, Edward Franek, Jake A. Kushner, Pablo Lapuerta, Darren K. McGuire, Anne L. Peters, Sangeeta Sawhney and Paul Strumph
    Diabetes Care 2018 Sep; 41 (9): 1981-1990. https://doi.org/10.2337/dc18-0342
    Add to Selected Citations
  • You have accessRestricted Access
    The Impact of Glycated Hemoglobin (HbA1c) on Cardiovascular Disease Risk: A Mendelian Randomization Study Using UK Biobank
    Shiu Lun Au Yeung, Shan Luo and C. Mary Schooling
    Diabetes Care 2018 Sep; 41 (9): 1991-1997. https://doi.org/10.2337/dc18-0289
    Add to Selected Citations
  • You have accessRestricted Access
    Incretin-Based Therapies and Diabetic Retinopathy: Real-World Evidence in Older U.S. Adults
    Tiansheng Wang, Jin-Liern Hong, Emily W. Gower, Virginia Pate, Seema Garg, John B. Buse and Til Stürmer
    Diabetes Care 2018 Sep; 41 (9): 1998-2009. https://doi.org/10.2337/dc17-2285
    Add to Selected Citations
  • You have accessRestricted Access
    Performance of Cardiovascular Disease Risk Scores in People Diagnosed With Type 2 Diabetes: External Validation Using Data From the National Scottish Diabetes Register
    Stephanie H. Read, Merel van Diepen, Helen M. Colhoun, Nynke Halbesma, Robert S. Lindsay, John A. McKnight, David A. McAllister, Ewan R. Pearson, John R. Petrie, Sam Philip, Naveed Sattar, Mark Woodward and Sarah H. Wild, on behalf of the Scottish Diabetes Research Network Epidemiology Group
    Diabetes Care 2018 Sep; 41 (9): 2010-2018. https://doi.org/10.2337/dc18-0578
    Add to Selected Citations
  • You have accessRestricted Access
    Poor Glycemic Control Is Associated With Increased Extracellular Volume Fraction in Diabetes
    Ahmed Al-Badri, Zeba Hashmath, Garrett H. Oldland, Rachana Miller, Khuzaima Javaid, Amer Ahmed Syed, Bilal Ansari, Swetha Gaddam, Walter R. Witschey, Scott R. Akers and Julio A. Chirinos
    Diabetes Care 2018 Sep; 41 (9): 2019-2025. https://doi.org/10.2337/dc18-0324
    Add to Selected Citations

Position Statement

  • Open Access
    Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association
    Jane L. Chiang, David M. Maahs, Katharine C. Garvey, Korey K. Hood, Lori M. Laffel, Stuart A. Weinzimer, Joseph I. Wolfsdorf and Desmond Schatz
    Diabetes Care 2018 Sep; 41 (9): 2026-2044. https://doi.org/10.2337/dci18-0023
    Add to Selected Citations

Standards of Care Updates

  • Open Access
    Updates to the Standards of Medical Care in Diabetes—2018
    Association American Diabetes
    Diabetes Care 2018 Sep; 41 (9): 2045-2047. https://doi.org/10.2337/dc18-su09
    Add to Selected Citations

Errata

  • Open Access
    Erratum. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP. Diabetes Care 2017;40:1733–1738
    Leo F. Buckley, Dave L. Dixon, George F. Wohlford, Dayanjan S. Wijesinghe, William L. Baker and Benjamin W. Van Tassell
    Diabetes Care 2018 Sep; 41 (9): 2048. https://doi.org/10.2337/dc18-er09
    Add to Selected Citations
  • Open Access
    Erratum. Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective. Diabetes Care 2018;41:1125–1131
    David Beran, Irl B. Hirsch and John S. Yudkin
    Diabetes Care 2018 Sep; 41 (9): 2048. https://doi.org/10.2337/dc18-er09a
    Add to Selected Citations

Issues and Events

  • Open Access
    Issues and Events
    Diabetes Care 2018 Sep; 41 (9): 2049. https://doi.org/10.2337/dc18-ie09
    Add to Selected Citations

e-Letters

  • Observations

    • Open Access
      Bullous Pemphigoid and Dipeptidyl Peptidase 4 Inhibitors: A Disproportionality Analysis Based on the Japanese Adverse Drug Event Report Database
      Masanori Arai, Jun Shirakawa, Hiromi Konishi, Naoko Sagawa and Yasuo Terauchi
      Diabetes Care 2018 Sep; 41 (9): e130-e132. https://doi.org/10.2337/dc18-0210
      Add to Selected Citations
    • Open Access
      Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide
      Jakob Schöllhammer Knudsen, Reimar Wernich Thomsen, Anton Pottegård, Filip Krag Knop and Henrik Toft Sørensen
      Diabetes Care 2018 Sep; 41 (9): e133-e135. https://doi.org/10.2337/dc18-0999
      Add to Selected Citations
  • Comments and Responses

    • Open Access
      Comment on Bril et al. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients. Diabetes Care 2018;41:187–192
      Brian L. Pearlman, Andrew Hinds and Alexandra-Elise Zakaud Dakaud
      Diabetes Care 2018 Sep; 41 (9): e136. https://doi.org/10.2337/dc18-0946
      Add to Selected Citations
    • Open Access
      Response to Comment on Bril et al. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients. Diabetes Care 2018;41:187–192
      Fernando Bril and Kenneth Cusi
      Diabetes Care 2018 Sep; 41 (9): e137-e138. https://doi.org/10.2337/dci18-0026
      Add to Selected Citations
Back to top
PreviousNext
Diabetes Care: 41 (9)

In this Issue

September 2018, 41(9)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)

Jump to

  • In This Issue
  • Perspectives in Care
  • Commentaries
  • Clinical Care/Education/Nutrition/Psychosocial Research
  • Epidemiology/Health Services Research
  • Emerging Therapies: Drugs and Regimens
  • Pathophysiology/Complications
  • Cardiovascular and Metabolic Risk
  • Position Statement
  • Standards of Care Updates
  • Errata
  • Issues and Events
  • e-Letters
    • Observations
    • Comments and Responses
  • Most Read
  • Most Cited
Loading
  • 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021
  • 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
  • 6. Glycemic Targets: Standards of Medical Care in Diabetes—2021
  • 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021
  • Table 1—Système International (SI) units for plasma, serum, or blood concentrations
More...

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.